Clinical Trial Demonstrates Significant Improvement for Women With Advanced or Recurrent Endometrial Cancer
NRG Oncology NRG-GY018 study demonstrates significantly improved progression free survival outcomes for women with advanced or recurrent endometrial cancer with the addition of pembrolizumab to…